Merck In Heart Drug Deal With ElexoPharm | May 24, 2010 Issue - Vol. 88 Issue 21 | Chemical & Engineering News
Volume 88 Issue 21 | p. 19 | Concentrates
Issue Date: May 24, 2010

Merck In Heart Drug Deal With ElexoPharm

Department: Business
Keywords: contract research, cardiovascular disease

Merck & Co. and German contract research organization ElexoPharm will work together to develop novel drug candidates targeting aldosterone synthase for the treatment of cardiovascular disease. Elexo­Pharm scores $1.9 million up front and could receive another $40 million in milestones throughout the course of the pact. ElexoPharm was spun out of Saarland University’s department of pharmaceutical and medicinal chemistry in 2005.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment